Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Shield’s Feraccru accepted for review in the US

pharmatimesDecember 06, 2018

Tag: Shield , Feraccru , oral formulation , iron deficiency

PharmaSources Customer Service